Plus-Nj

KU is a biopharmaceutical company specializing in RNA interference (RNAi) therapeutics, which represent a groundbreaking approach to treating diseases by silencing the genes responsible for them. Committed to delivering transformational medicines, KU aims to benefit a wide range of patients through its robust pipeline of investigational RNAi-based treatments targeting both rare and prevalent diseases.

Driven by science and inspired by the stories of patients, KU fosters an inclusive workplace where innovation thrives. The company embraces its role as a positive force in the world, believing that its impact extends beyond the medicines it creates.

Generated from the website